NOVO-NORDISK AS (NVO)
NYSEHealth CareDrug Manufacturers - GeneralSnapshot 2026-09-04
$46.60-1.92%
Close 2026-09-04 · 1-day change
NYSEHealth CareDrug Manufacturers - GeneralSnapshot 2026-09-04
QuarterlyIQ Insights · NVO
What must go right, what could break, what the price assumes, and what evidence comes next.
The current health of the standing investment case.
No current thesis-health read is available for this company.
One-year growth currently built into the price, compared with our model's estimate.
A comparable price-assumption read is not available for this company.
For each item: what to watch, what would become a concern, and what would make it less concerning.
A reporting-risk estimate, not a forecast of the stock-price response.
Historical relationships that met the evidence threshold. They do not prove cause or forecast a move.
Usually moved in the same direction.
Price observations: 365 days
Most sensitive to the broad stock market.
Based on historical daily prices through 2026-09-04.
Past price behavior in dollars on a $10,000 position. This does not measure permanent business risk.
How much price usually moves either way.
A larger daily loss that occurred about once in every 20 trading days.
Use the underlying financial and sector pages to investigate the cause.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Model as of 2026-09-04 · Compared with 10 industry peers · Company calendar date is not available
Why it matters: If revenue growth speeds up, it could signal a strong recovery in the sector. This would be important for Novo Nordisk as it navigates a maturing phase.
Supportive ifRevenue growth speeds up to over 10% each year.
Worry ifRevenue growth remains below 9% year over year.
Why it matters: A drop below median revenue growth would signal a slowdown in the sector's expansion. This could impact investor confidence in NOVO-NORDISK's growth prospects.
Worry ifRevenue growth falls below the median growth rate for the health care sector.
Less concerning ifRevenue growth remains above the median growth rate for the health care sector.
Why it matters: Consumer Price Index data can influence health care costs and pricing strategies. High inflation could pressure margins.
Watch forCPI data shows inflation is under 2%. This means prices are stable.
Also watch forCPI data shows inflation above 4%, indicating rising costs for health care.
Why it matters: GDP growth impacts overall economic health. Strong GDP can boost health care spending, while weak GDP may reduce it.
Watch forGDP growth is over 3%. This shows the economy is strong.
Also watch forGDP growth is under 1%. This shows the economy is weak.
We watch for confirming and disproving signals on each item. Resolutions are found automatically where possible and checked by hand for unclear cases. Last 90 days shown.
Deepest peak-to-trough drop in the last year.
| Measure | Value | Meaning |
|---|---|---|
| Typical day | ±$142 on $10,000 · ±1.4% | How much price usually moves either way. |
| Bad day | $310 loss on $10,000 · 3.1% | A larger daily loss that occurred about once in every 20 trading days. |
| Largest peak-to-trough drop in the past year | $4,367 loss on $10,000 · 43.7% | Deepest peak-to-trough drop in the last year. |
Past year. 1.00 means similar movement; 1.20 means about 20% more.
Past year. 1.00 means similar movement to the sector. This is secondary context.
Latest 30 trading days, shown as an annual percentage.
Latest 252 trading days, shown as an annual percentage.
20-trading-day average in US dollars.
Trading days used by the source risk snapshot.
Past results, not a forecast. Not investment advice.
Why it matters: If the health care sector outperforms, it could lift NOVO-NORDISK shares. Strong sector performance often helps individual stocks.
Supportive ifHealth care sector shows a relative performance increase of more than 5% over the next 60 days.
Worry ifHealth care sector underperforms by more than 5% over the next 60 days.
Why it matters: If revenue growth speeds up, it may show a stronger market for Novo Nordisk.
Supportive ifSector revenue growth is speeding up to 12% each year.
Worry ifSector revenue growth is slowing down to below 8% each year.
Why it matters: The Producer Price Index affects costs and pricing for drug companies.
Watch forPPI shows an increase above 0.3% month over month.
Also watch forPPI shows a decrease below 0.1% month over month.
Why it matters: The Consumer Price Index affects how much people spend and healthcare needs.
Watch forCPI shows an increase above 0.4% month over month.
Also watch forCPI shows a decrease below 0.2% month over month.